MMED Earnings & Financial Statements
MMED
$17.40
+$0.59(+3.51%)
60
Overall
60
Value
60
Tech
60
Quality
Market Cap
$4.73B
Volume
2.41M
52W Range
$10.65 - $24.43
Target Price
$24.92
MMED earnings and financial statements: MMED's income statement, balance sheet and cash flow statement, annual and quarterly.
MMED Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B | $2.25B |
| Cost of revenue | $1.42B | $1.19B | $1.03B | $937.00M |
| Operating income | -$190.00M | -$161.00M | -$68.00M | -$93.00M |
| EBITDA | -$33.00M | -$19.00M | $60.00M | $15.00M |
| Net income | -$333.00M | -$229.00M | -$112.00M | -$121.00M |
| EPS (diluted) | $-1.30 | $-0.84 | - | - |
| Fiscal year | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total assets | $4.63B | $4.20B | $4.09B | $4.02B |
| Total liabilities | $1.02B | $871.00M | $646.00M | $618.00M |
| Shareholders’ equity | $3.61B | $3.33B | $3.45B | $3.40B |
| Cash and equivalents | $298.00M | $11.00M | $54.00M | $58.00M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating cash flow | -$197.00M | $140.00M | $40.00M | -$4.00M |
| Free cash flow | -$420.00M | -$53.00M | -$108.00M | -$171.00M |
| Dividends paid | $229.00M | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MMED | $17.40 | +3.5% | 2.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |